Galectin Therapeutics Inc (GALT)’S -2.65% Retreat Makes It Worth Considering Again
Galectin Therapeutics Inc (NASDAQ:GALT) concluded the trading at $1.10 on Friday, January 10 with a fall of -2.65% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $1.13 and 5Y monthly beta